Patients with higher tumor grade (G3+G4) had increased GLUT-1 expression than patients with lower tumor grade (G1+G2): OR = 3.34, 95%CI: 1.12–9.94, P = 0.031 (Fig. 2B). The gene discussed is SLC2A1; the disease is neoplasm.